NorthX Biologics AB introduces proprietary AAV plasmids, bolstering comprehensive gene therapy support
NorthX Biologics AB, a pioneer in biopharmaceutical innovation, is excited to announce the launch of its proprietary plasmids for the efficient manufacture of AAV (Adeno-Associated Virus) vectors for gene therapy. ...
More than a hundred advanced biologics frontrunners gathered at our first-class manufacturing site in Matfors
The future of advanced biologics On 26-28 September NorthX successfully arranged the conference ”the future of advanced biologics” where over 100 front-runners from the life science field were invited to ...
NorthX Biologics AB announces inauguration of Innovation Hub at Matfors facility
Matfors, Sweden (September 28 2023) NorthX Biologics AB (“NorthX”) is proud to announce the official inauguration of its state-of-the-art Innovation Hub at the Matfors facility. This significant milestone marks a ...
NorthX Biologics welcomes Dr Janet Hoogstraate as new CEO following merger with Valneva Clinical Trials Manufacturing unit
We are announcing the appointment of a new CEO Dr. Janet Hoogstraate. Janet is a distinguished leader within the biopharmaceutical sector and this move follows the company’s strategic merger with Valneva ...
NorthX Biologics acquires the Stockholm-based Clinical Trial Manufacturing unit from Valneva Sweden
NorthX Biologics, a leading Nordic development and manufacturing organisation announces acquisition of a biologics manufacturing unit from Valneva MATFORS, Sweden, July 03, 2023 (GLOBE NEWSWIRE) NorthX Biologics (‘NorthX’), a leading ...
Covid-19 vaccine that can cope with mutated viruses in clinical phase 1 study at Karolinska University Hospital
A new DNA-based vaccine against covid-19 is being tested for the first time on healthy participants at Karolinska University Hospital. The vaccine has been developed at Karolinska Institutet and target ...
Mendus and NorthX Biologics to enter into strategic cell therapy manufacturing alliance supported by new investor Flerie
Mendus AB, a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announces that it has entered into a manufacturing alliance with NorthX Biologics AB. NorthX is a Contract Development ...
NorthX Biologics enters as a partner in AdBIOPRO, Competence Centre for Advanced BioProduction
NorthX Biologics is proud to have the opportunity to support and be a part of AdBIOPRO. “It is a great infrastructure for ground breaking research and development aimed at finding ...
The factory in Matfors aims to become a magnet for development work!
Now you can read the exciting article about the innovation factory on Dagens Industri. The digital link can be found here!